Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2003
04/18/2003CA2463482A1 Microbes having an attenuating mutation comprising a transcription terminator
04/17/2003WO2003031939A2 Protein modification and maintenance molecules
04/17/2003WO2003031628A1 Secretory polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
04/17/2003WO2003031627A1 Platelet-origin polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
04/17/2003WO2003031595A2 Molecules for disease detection and treatment
04/17/2003WO2003031578A2 Mammalian c-type lectins
04/17/2003WO2003031568A2 Intracellular signaling molecules
04/17/2003WO2003031476A1 Antibody of human origin for inhibiting thrombocytes aggregation
04/17/2003WO2003031475A2 Antibodies against kdr, their production and uses
04/17/2003WO2003031473A1 Leukocyte inactivation module
04/17/2003WO2003031464A2 Remodeling and glycoconjugation of peptides
04/17/2003WO2003031459A2 Modulation of the expression of genes dependent on stat-1
04/17/2003WO2003031447A2 Pyrimidine derivatives
04/17/2003WO2003031445A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
04/17/2003WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003WO2003031438A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003WO2003031432A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
04/17/2003WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent
04/17/2003WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
04/17/2003WO2003031396A1 Salts of guanidine derivatives and pharmaceutical preparations consisting thereof
04/17/2003WO2003030965A2 Artificial lymph node
04/17/2003WO2003030947A2 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
04/17/2003WO2003030944A2 Inhibition of stat-1
04/17/2003WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003WO2003030939A1 Therapies for treating respiratory diseases
04/17/2003WO2003030935A2 Adjuvants for nucleic acid vaccines
04/17/2003WO2003030930A1 Human 3 relaxin
04/17/2003WO2003030919A1 Method of obtaining an extract of ginger
04/17/2003WO2003030905A1 Dihydroorotate dehydrogenase inhibitor
04/17/2003WO2003030904A1 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide
04/17/2003WO2003030902A1 Imidazole derivates as anti-inflammatory agents
04/17/2003WO2003030897A1 Pyrrolidinone derivatives
04/17/2003WO2003030889A1 Para-amino benzoic acids as integrin antagonists
04/17/2003WO2003030883A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
04/17/2003WO2003030876A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003WO2003030827A2 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003WO2003030824A2 Methods and compositions for treating dermal lesions
04/17/2003WO2003030823A2 Combinations for the treatment of immunoinflammatory disorders
04/17/2003WO2003030656A2 Methods and compositions for promoting growth and innate immunity in young animals
04/17/2003WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor
04/17/2003WO2003011293A3 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
04/17/2003WO2003008457A3 Polysaccharidic esters of retinoic acid
04/17/2003WO2002094863A3 INTERFERON-α INDUCED GENE
04/17/2003WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof
04/17/2003WO2002083700A3 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
04/17/2003WO2002083072A3 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
04/17/2003WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them
04/17/2003WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof
04/17/2003WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof
04/17/2003WO2002050289A9 Methods for the production of multimeric proteins, and related compositions
04/17/2003WO2002050284A3 Oxidoreductases
04/17/2003WO2002047704A9 Herbal pharmaceutical compositions for treating immunological disorders
04/17/2003WO2002041871A3 Composition comprising an imexon or derivatives thereof and lipids
04/17/2003WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
04/17/2003WO2002032445A3 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof
04/17/2003WO2002029036A3 Lipid metabolism enzymes
04/17/2003WO2002024891A3 B7-like molecules and uses thereof
04/17/2003WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
04/17/2003WO2002018575A3 Genes expressed in the cell cycle
04/17/2003WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
04/17/2003WO2002017881A3 Transdermal pharmaceutical delivery composition
04/17/2003WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same
04/17/2003WO2001072752A3 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS
04/17/2003WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands
04/17/2003WO1994020127A9 Hla-a2.1 binding peptides and their uses
04/17/2003US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
04/17/2003US20030073822 Blood group antigen fusion polypeptides and method of use thereof
04/17/2003US20030073727 Central nervous system disorders
04/17/2003US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens
04/17/2003US20030073720 Tryptase inhibitors
04/17/2003US20030073719 Chiral salt resolution
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073703 Autoimmune disease; antiinflammatory agents
04/17/2003US20030073699 Compounds and methods to treat cardiac failure and other disorders
04/17/2003US20030073693 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
04/17/2003US20030073692 Anticancer agents; viricides; Alzheimer's diseases
04/17/2003US20030073690 Controlling pain in mammals
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073676 Dissolving in aqueous carrier; antiallergens
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073223 For use in vaccines
04/17/2003US20030073167 DNA encoding SNORF36 receptors
04/17/2003US20030073142 Immunoglobulin E vaccines and methods of use thereof
04/17/2003US20030073094 Stress proteins and uses therefor
04/17/2003US20030073072 Chimeric adenoviruses
04/17/2003US20030072774 Proteinaceous adjuvants
04/17/2003US20030072768 Method to enhance an immune response of nucleic acid vaccination
04/17/2003US20030072767 Compositions and methods for WT1 specific immunotherapy
04/17/2003US20030072762 For enhancing Fc receptor-mediated antigen presentation, vaccines
04/17/2003US20030072759 Administering to a patient afflicted with a gastrointestinal tumor, a murine monoclonal antibody which specifically binds to an epitope of 17-1A antigen, the antibody being administered parenterally in multiple doses
04/17/2003US20030072754 CD154 blockade therapy for pancreatic islet tissue transplantation
04/17/2003US20030072751 Idiotypic vaccination against b cell lymphoma
04/17/2003US20030072742 Enhancement of immune response using targeting molecules
04/17/2003US20030072736 Human tumor necrosis factor receptor TR16
04/17/2003CA2473970A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
04/17/2003CA2464662A1 Modulation of the expression of genes dependent on stat-1
04/17/2003CA2463496A1 Method of obtaining an extract of ginger
1 ... 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 ... 1172